Axo Longevity
Axo Longevity is a preventive-health membership that combines recurring laboratory testing with personalised insights and an AI health coach.
$5MSeed
ParticipantLV
LifeX Ventures
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Jan 1, 2026
LifeX Ventures is an AI and healthcare investment firm whose current portfolio includes Axo Longevity, Integral Privacy Technologies and Konko AI.
Recorded funding activity
Axo combines preventive-health testing with personalized insights. Konko develops patient-communication software, while Integral prepares data for AI use. The firm portfolio is distinct from its separately labeled previous personal investments and unrelated LifeX namesakes.
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $130.6M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionKonko AI
Konko AI builds Kora, a patient-communications assistant for clinics and hospitals.
$6MFunding
ParticipantIntegral Privacy Technologies
Transforms real-world data into AI-ready assets for training, labeling, and enterprise AI applications
$18MSeries A
Role not disclosedCellbricks Therapeutics
Develops biofabricated human tissue implants and aims to manufacture 3D-printed organs
€10MSeed+Non-Dilutive
Role not disclosedNoTraffic
Develops AI-powered mobility platform for traffic management
$90MSeries C
Role not disclosed